help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, W. C.
Right arrow Articles by Talamantes, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, W. C.
Right arrow Articles by Talamantes, F.

Endocrinology, Vol 123, 1489-1494, Copyright © 1988 by Endocrine Society


ARTICLES

Gestational profile and affinity cross-linking of the mouse serum growth hormone-binding protein

WC Smith and F Talamantes
Department of Biology, University of California, Santa Cruz 95064.

The modulation of the serum concentration of mouse GH-binding protein during gestation was characterized. A rapid increase in the concentration of the binding protein began on day 9 of pregnancy and peaked by day 15. The increase in the serum GH-binding protein concentration was preceded several days by an increase in the hepatic GH receptor concentration. The serum GH-binding protein was recognized by antibodies produced against the hepatic GH receptor, and its mol wt (major form mol wt, approximately 41,800) was similar to that of low mol wt forms of the hepatic GH receptor, demonstrating the similarity of the serum GH-binding protein and the hepatic GH receptor. The apparent affinity of the serum GH-binding protein for mGH in untreated serum samples from 17-day pregnant mice was 6.9 X 10(7) M-1. However, when the serum was treated to remove endogenous GH, the apparent affinity increased to 1.5 X 10(8) M-1. Likewise, the binding capacity of the GH-binding protein in serum differed in treated (60.1 nM) and untreated serum (101.2 nM).


This article has been cited by other articles:


Home page
EndocrinologyHome page
K.-C. Leung, N. Doyle, and K. K. Y. Ho
Characterization of a Low Affinity Binding Protein for Growth Hormone in Rat Serum
Endocrinology, January 1, 2000; 141(1): 138 - 145.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. G. Camarillo, G. Thordarson, Y. N. Ilkbahar, and F. Talamantes
Development of a Homologous Radioimmunoassay for Mouse Growth Hormone Receptor
Endocrinology, August 1, 1998; 139(8): 3585 - 3589.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Tzanela, C. Wagner, and G. Shaffer Tannenbaum
Recombinant Human Growth Hormone-Binding Protein Fails to Enhance the in Vivo Bioactivity of Human Growth Hormone in Normal Rats
Endocrinology, December 1, 1997; 138(12): 5316 - 5324.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. I. Ymer, J. L. Stevenson, and A. C. Herington
Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity
Endocrinology, September 1, 1997; 138(9): 3577 - 3586.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society